Association of High-Density Lipoprotein Subclasses with Chronic Kidney Disease Progression, Atherosclerosis, and Klotho

被引:12
|
作者
Kanda, Eiichiro [1 ,2 ]
Al, Masumi [3 ]
Okazaki, Mitsuyo [4 ]
Yoshida, Masayuki [2 ]
Maeda, Yoshitaka [5 ]
机构
[1] Tokyo Kyosai Hosp, Dept Nephrol, Meguro Ku, Tokyo, Japan
[2] Tokyo Med & Dent Univ, Grad Sch Med, Dept Life Sci & Bioeth, Bunkyo Ku, Tokyo, Japan
[3] Tokyo Med & Dent Univ, Grad Sch Med, Dept Insured Med Care Management, Bunkyo Ku, Tokyo, Japan
[4] Tokyo Med & Dent Univ, Bunkyo Ku, Tokyo, Japan
[5] JA Toride Med Ctr, Dept Nephrol, Toride, Ibaraki, Japan
来源
PLOS ONE | 2016年 / 11卷 / 11期
关键词
FIBROBLAST GROWTH FACTOR-23; INSULIN-RESISTANCE; PREDIALYSIS PATIENTS; DOWN-REGULATION; RENAL-DISEASE; CHOLESTEROL; RISK; DYSLIPIDEMIA; GENE; METABOLISM;
D O I
10.1371/journal.pone.0166459
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Atherosclerosis is often a complication of chronic kidney disease (CKD) because of dyslipidemia and CKD-mineral and bone disorder. High-density lipoproteins (HDLs) are grouped into various subclasses composed of multiple proteins and lipids, and their transformation is altered in CKD. We investigated the roles of lipoprotein subclasses in CKD progression, and atherosclerosis, and the relationships with Klotho and fibroblast growth factor (FGF) 23. Methods Seventy-one CKD patients were enrolled in this prospective cohort study in Japan. The proportions of cholesterol level to total cholesterol level (cholesterol proportion) and lipoprotein particle numbers in 20 lipoprotein fractions were measured by a newly developed high-performance gel permeation chromatography. Results Diabetic nephropathy was observed in 23.9% of the patients. The mean age was 75.0 years and estimated glomerular filtration rate (eGFR) was 17.2 ml/min./1.73m(2). The lipoprotein particle numbers in small HDLs were higher in Stage 4 group than in Stage 5 group (p = 0.002). Multivariate regression analysis adjusted for baseline characteristics showed that the cholesterol proportions in very small HDLs were associated with eGFR change rate [F19 beta = -17.63, p = 0.036] and ABI [F19 beta = 0.047, p = 0.047] in Stage 4 group, and that serum soluble a-Klotho level was associated with the lipoprotein particle numbers in very small HDLs [F19 beta = 0.00026, p = 0.012; F20 beta = 0.00041, p = 0.036] in Stage 5 group. Conclusions This study showed that HDL subclasses are associated with CKD progression, ABI, and Klotho level in CKD-stage-specific manner.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] High-Density Lipoprotein Lipidomics in Chronic Kidney Disease
    Lidgard, Benjamin
    Hoofnagle, Andrew N.
    Zelnick, Leila R.
    de Boer, Ian H.
    Fretts, Amanda M.
    Kestenbaum, Bryan R.
    Lemaitre, Rozenn N.
    Robinson-Cohen, Cassianne
    Bansal, Nisha
    CLINICAL CHEMISTRY, 2023, 69 (03) : 273 - 282
  • [2] High-density lipoprotein subclasses and their relationship to cardiovascular disease
    Superko, H. Robert
    Pendyala, Lakshmana
    Williams, Paul T.
    Momary, Katherine M.
    King, Spencer B., III
    Garrett, Brenda C.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2012, 6 (06) : 496 - 523
  • [3] Association between cumulative uric acid to high-density lipoprotein cholesterol ratio and the incidence and progression of chronic kidney disease
    Liu, Peipei
    Li, Junjuan
    Yang, Ling
    Zhang, Zihao
    Zhao, Hua
    Zhao, Naihui
    Ou, Wenli
    Zhang, Yinggen
    Chen, Shuohua
    Wang, Guodong
    Zhang, Xiaofu
    Wu, Shouling
    Yang, Xiuhong
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [4] High-Density Lipoprotein and Low-Density Lipoprotein Subfractions in Patients with Chronic Kidney Disease
    Rysz-Gorzynska, Magdalena
    Gluba-Brzozka, Anna
    Banach, Maciej
    CURRENT VASCULAR PHARMACOLOGY, 2017, 15 (02) : 144 - 151
  • [5] High-density lipoprotein cholesterol and causes of death in chronic kidney disease
    Navaneethan, Sankar D.
    Schold, Jesse D.
    Walther, Carl P.
    Arrigain, Susana
    Jolly, Stacey E.
    Virani, Salim S.
    Winkelmayer, Wolfgang C.
    Nally, Joseph V., Jr.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2018, 12 (04) : 1061 - 1071
  • [6] Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease
    Moradi, Hamid
    Pahl, Madeleine V.
    Elahimehr, Reza
    Vaziri, Nosratola D.
    TRANSLATIONAL RESEARCH, 2009, 153 (02) : 77 - 85
  • [7] HIGH-DENSITY LIPOPROTEIN AND ATHEROSCLEROSIS
    HARVENGT, C
    ACTA CLINICA BELGICA, 1978, 33 (02): : 73 - 77
  • [8] HIGH-DENSITY LIPOPROTEIN AND ATHEROSCLEROSIS
    MILLER, NE
    MILLER, GJ
    LANCET, 1975, 1 (7914): : 1033 - 1033
  • [9] HIGH-DENSITY LIPOPROTEIN AND ATHEROSCLEROSIS
    AVOGARO, P
    CAZZOLATO, G
    PAIS, M
    LANCET, 1975, 1 (7908): : 692 - 692
  • [10] THE ASSOCIATION BETWEEN MONOCYTE TO HIGH-DENSITY LIPOPROTEIN CHOLESTEROL RATIO AND CARDIOVASCULAR DISEASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Naouaoui, Salma
    Chettati, Mariam
    Fadili, Wafaa
    Laouad, Inass
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I414 - I414